NASDAQ · Biotechnology

GRI (GRI) Stock

$1.46 -5.81% NASDAQ: GRI Healthcare

Valuation

MetricValue
Price$1.46
Market Cap$131155
P/E Ratio-0.33
P/B Ratio0.24
P/S Ratio0.00
EPS (TTM)$-7.98
52-Week High$80.36
52-Week Low$1.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-381.74%
ROA-206.45%
ROCE-199.35%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio3.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$23.0M$0
Operating Profit$-9.0M$-2.0M$-11.0M$-8.0M$-12.0M
Net Profit$-9.0M$-3.0M$-13.0M$-8.0M$-12.0M
EPS$-2827.16$-47135.48$-140450.24$-1545.88$-121.80
Op Margin———-36.5%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$3.0M$6.0M$9.0M
Total Liabilities$5.0M$2.0M$3.0M$2.0M$3.0M
Cash$0$0$2.0M$5.0M$8.0M
Borrowings$4.0M$1.0M$0$0$0

Latest News

GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase GlobeNewswire · May 18, 2026 GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline GlobeNewswire · May 14, 2026 GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions GlobeNewswire · Apr 8, 2026 How The Grainger (LSE:GRI) Investment Story Is Evolving As The Narrative Holds Steady Simply Wall St. · Apr 4, 2026 3 Undervalued Small Caps In Global With Recent Insider Activity Simply Wall St. · Apr 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-9.0M$-9.0M$-10.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$-3.0M$-1.0M$-2.0M
Net Cash Flow$0$0$2.0M$3.0M$3.0M
Free Cash Flow$-1.0M$-1.0M$-9.0M$-9.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-6141.78%
Quick Ratio14.21
Interest Coverage—
Return 1Y-96.79%
Return 3Y-100.00%
Return 5Y-100.00%

Ownership

Insiders Held0.46%
Institutions Held2.80%
Institutions Float Held2.81%
Institutional HolderSharesReport Date
Geode Capital Management, LLC18,4382026-03-31
UBS Group AG8,7222026-03-31
Tower Research Capital LLC (TRC)1,0602026-03-31
SBI Securities Co., Ltd.42026-03-31
Danske Bank A/s22026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABPAbpro Corporation $0.52 — -0.02 $1.06M 0.00%
BDRXBiodexa Pharmaceuticals Plc $1.71 -3.39% 0.00 $1.28M 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CLDI $0.11 +0.18% -0.03 $802266 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%

About GRI

GRI is led by CEO W. Marc Hertz, employs 3 people, headquartered in US, publicly traded since 2023.

GRI stock trades at $1.46 with a market capitalization of $131155. The stock is valued at a price-to-earnings (P/E) ratio of -0.33, price-to-book of 0.24, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.40 and $80.36, and currently trades 98.2% below its 52-week high.

On profitability, GRI generates a return on equity (ROE) of -381.74%, return on capital employed of -199.35%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides